December 28, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
December 22, 2023 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
December 19, 2023 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
December 18, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
December 13, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
December 12, 2023 Press release - Regulatory TG01 IND application filed in China by Circio’s partner IOVaxis Therapeutics
December 7, 2023 Press release - Regulatory Circio announces completion of planned safety review and opening for full enrollment of TG01 study at Oslo University Hospital
November 30, 2023 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
November 29, 2023 Press release - Non-regulatory Reminder: Circio invites to circular RNA R&D webinar today
November 24, 2023 Press release - Non-regulatory Circio announces outcome of TG01/gemcitabine combination EU patent proceeding
November 21, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
November 16, 2023 Press release - Non-regulatory Circio inngår nytt samarbeid i USA for å teste kreftvaksinen TG01 i RAS-mutert kreft
November 16, 2023 Press release - Non-regulatory Circio joins collaboration to test the combination of TG01 vaccination with daratumumab and nivolumab in immunotherapy resistant patients with mutant RAS cancers
November 9, 2023 Press release - Non-regulatory Circio invites to circular RNA R&D webinar Wednesday 29 November 2023
October 26, 2023 Press release - Non-regulatory Circio presents powerful expression data for new generation circVec 2.0 design at the ESGCT 2023 annual meeting
October 19, 2023 Press release - Non-regulatory Circio: circRNA poster to be presented at the 30th European Society for Gene and Cell Therapy (ESGCT)
October 18, 2023 Press release - Regulatory Circio strengthens its focus on next generation circular RNA therapeutics with additional cost reductions
October 10, 2023 Press release - Non-regulatory Circio and Neoregen Biotech enter collaboration for delivery of novel circular RNA therapeutics using NICT technology
October 4, 2023 Press release - Non-regulatory Circio invites to a company update on Wednesday 11 October 2023
October 2, 2023 Press release - Regulatory Circio Holding ASA – Key information relating to the change of ISIN
October 2, 2023 Press release - Regulatory Circio Holding ASA – Key information relating to the reverse share split
September 28, 2023 Press release - Regulatory Circio Holding ASA: Approval and publication of registration document
September 27, 2023 Press release - Regulatory Circio Holding ASA: Minutes from the Extraordinary General Meeting
September 25, 2023 Press release - Non-regulatory Circio: circRNA poster to be presented at the 15th international adenovirus meeting
September 21, 2023 Press release - Regulatory Circio Holding ASA – Technical adjustment to item 7 in the Notice of the Extraordinary General Meeting to be held on 27 September 2023
September 21, 2023 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
September 14, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
September 7, 2023 Press release - Non-regulatory Circio invites to Q&A webcast regarding Extraordinary General Meeting
September 6, 2023 Press release - Regulatory Circio Holding ASA – Notice of Extraordinary General Meeting
September 4, 2023 Press release - Non-regulatory ONCOS-102 mesothelioma study published in Journal for ImmunoTherapy of Cancer
August 15, 2023 Press release - Non-regulatory Circio Holding ASA: Invitation to Circio’s first half year 2023 presentation, Thursday 24 August
June 29, 2023 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
June 26, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
June 22, 2023 Press release - Non-regulatory Circio: Første pasient med benmargskreft dosert med TG01 i studie på Oslo Universitetssykehus
June 22, 2023 Press release - Non-regulatory Circio: First patient in multiple myeloma trial dosed with TG01 at Oslo University Hospital
June 12, 2023 Press release - Regulatory Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members
May 31, 2023 Press release - Non-regulatory Circio invites to a company update on Thursday 15 June 2023
May 26, 2023 Press release - Regulatory Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
May 23, 2023 Press release - Regulatory Circio Holding ASA: Requested Conversion of Convertible Bonds
May 16, 2023 Press release - Non-regulatory Circio: Link to recording and presentation from Company update 16[th] May 2023
May 3, 2023 Press release - Regulatory Targovax ASA – Correction of the proxy form attached to the notice of the Annual General Meeting
May 3, 2023 Press release - Non-regulatory Circio: circRNA poster to be presented at the ASGCT Annual Meeting
April 19, 2023 Press release - Regulatory Targovax skifter navn til Circio og styrker satsingen på sirkulært RNA
April 19, 2023 Press release - Regulatory Targovax to rebrand as Circio, an innovator in next generation circular RNA therapeutics
April 13, 2023 Press release - Non-regulatory Targovax ASA: Registration of share capital increase following conversion of convertible bonds
March 30, 2023 Press release - Non-regulatory Targovax ASA: Requested Conversion of Convertible Bonds
March 15, 2023 Press release - Non-regulatory Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting
March 9, 2023 Press release - Regulatory Targovax ASA: Minutes from the Extraordinary General Meeting
March 7, 2023 Press release - Regulatory Targovax to prioritize resources on unlocking the potential of its circRNA platform
March 6, 2023 Press release - Regulatory Targovax ASA – Additional information prior to the Extraordinary General Meeting
March 6, 2023 Press release - Regulatory Targovax ASA: Registration of share capital increase following settlement of restricted stock units
March 2, 2023 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs
March 2, 2023 Press release - Regulatory Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital
March 1, 2023 Press release - Regulatory Targovax ASA – Additional information prior to the Extraordinary General Meeting
February 23, 2023 Press release - Regulatory Targovax invites to Q&A webcast regarding convertible bond financing
February 16, 2023 Press release - Regulatory Targovax annonserer finansiering på inntil 300 millioner til utvikling av kreftmedisin og ny sirkulær RNA plattform
February 16, 2023 Press release - Regulatory Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform
February 8, 2023 Press release - Regulatory Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February
